Joint Ventures Share The Risks For Multinational Pharmaceuticals

BMI View: Multinational pharmaceutical companies will partner with local sales and marketing firms based in emerging markets to increase the market penetration of their medicines. By leveraging the local expertise of trusted companies, transnational groups can increase returns while minimising operational risks. We note that some large firms will not adopt this strategy and will instead look to use their global marketing expertise to launch into local

To read the full article, please choose one of the following options: